Europe — EMA

Novorapid Flexpen (Insulin Aspart)

Request sourcing

Pack/s

What is Insulin Aspart?

Insulin aspart, the active ingredient in Novorapid Flexpen, is a rapid‑acting insulin analog presented as a solution for subcutaneous injection use. It controls blood glucose in people with diabetes mellitus. GNH USA supplies Novorapid Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Insulin Aspart used for?

Novorapid Flexpen is a rapid‑acting insulin analog that lowers blood glucose through the prandial pathway. - Type 1 Diabetes Mellitus: Improves post‑prandial glucose control. - Type 2 Diabetes Mellitus: Reduces mealtime‑related glycaemic fluctuations. - Gestational Diabetes Mellitus: Assists with tight glycemic control during pregnancy.

What are the side effects of Insulin Aspart?

Common Side Effects: - - . - .... ... ... ... ... ... ... ... .... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →